Pharma Foods (2929) Earnings: Operating Profit Up 11.2%, Net Income Surges 439.1%

Pharma Foods (2929) has released its financial results, reporting net sales of 63,223 million yen, a 3.1% decrease compared to the same period of the previous year. Despite the slight drop in revenue, profitability improved significantly; operating profit rose 11.2% year-on-year to 2,632 million yen, and net income attributable to owners of the parent surged 439.1% to 1,988 million yen. Ordinary profit stood at 2,440 million yen, down 4.4% year-on-year.

Examining profitability and the financial foundation, the operating profit margin was recorded at 4.2%. The return on equity (ROE) reached 16.1%, and the return on assets (ROA) stood at 7.2%, reflecting efficient asset utilization. Regarding cash flows, operating cash flow showed an outflow of 1,175 million yen, and investing cash flow recorded an outflow of 4,000 million yen. Meanwhile, financing cash flow generated an inflow of 3,808 million yen. With EBITDA at 3,370 million yen and an equity ratio of 37.5%, the company maintains a stable financial base while funding strategic growth initiatives.